On February 12, 2025, Gary K. Adams and Denise L. Ramos each informed the Board of Directors (the “Board”) of Phillips 66 (the “Company”) of their intent not to stand for reelection to the Board at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”).
On February 12, 2025, Gary K. Adams and Denise L. Ramos each informed the Board of Directors (the “Board”) of Phillips 66 (the “Company”) of their intent not to stand for reelection to the Board at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”).
Effective February 13, 2025, Milton H. Werner, Ph.D. resigned as President, Chief Executive Officer and principal executive officer of Inhibikase Therapeutics, Inc. (the “Company”) and as a member of the Board of Directors (the “Board”) of the Company (the “Resignation”).
Mr. LaRose became a full-time non-officer employee of the Company, and is expected to remain employed for a transition period ending on April 30, 2025.
On February 18, 2025, Norwood Financial Corp (the “Company”) announced that Susan Campfield retired from the Board of Directors of the Company and its wholly-owned subsidiary, Wayne Bank.
Departed
Preetam Shah
Chief Financial Officer
Cidara Therapeutics, Inc.
Effective
2025-02-24
Successor
Frank Karbe
Filed
February 18, 2025, 6:59 PM ET
On February 12, 2025, Cidara Therapeutics, Inc. (the “Company”) and Preetam Shah, Ph.D., MBA., the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, mutually agreed to Dr. Shah’s separation from such roles with the Company, effective February 24, 2025
On February 12, 2025, John Mazzola notified the Company that he intends to retire from his position as Chief Operating Officer of Vicarious Surgical Inc. (the “Company”), effective April 1, 2025.
On February 18, 2025, Christian Brühlmann resigned from his position as Chief Strategy Officer of the Company.
Departed
Robert W. Bourne
Senior Vice President and Chief Commercial Officer
Western Midstream Operating, LP
Effective
2025-03-03
Filed
February 18, 2025, 6:59 PM ET
On February 18, 2025, Robert W. Bourne, Senior Vice President and Chief Commercial Officer of Western Midstream Holdings, LLC (“WES GP”), the general partner of Western Midstream Partners, LP (“WES”), which owns Western Midstream Operating GP, LLC (the “General Partner”), the general partner of Western Midstream Operating, LP (the “Partnership”), entered into a Retirement Agreement and General Release (the “Retirement Agreement”) with WES.
Departed
Robert W. Bourne
Senior Vice President and Chief Commercial Officer
On February 18, 2025, Robert W. Bourne, Senior Vice President and Chief Commercial Officer of Western Midstream Holdings, LLC, the general partner of Western Midstream Partners, LP (“WES”), entered into a Retirement Agreement and General Release (the “Retirement Agreement”) with WES.
On February 15, 2025, Roderick K. West, a member of the Board of Directors (the “Board”) of Essential Utilities, Inc. (the “Company”) since 2023, informed the Company of his resignation as a director and as a member on all Board committees on which he served, effective immediately.
On February 11, 2025, Kathleen S. Pushor notified the Board of Directors (the “Board”) of Insight Enterprises, Inc. (the “Company”) that she intends to retire from the Board and will not stand for election at the Company’s next annual meeting of stockholders (the “2025 Annual Meeting”).
the Company and Sergio Cervantes, the Chief Financial Officer of the Company agreed that Mr. Cervantes’ employment would be terminated, effective February 16, 2025
Departed
Jeryl (Jeri) Hilleman
director
CUTERA INC
Effective
2025-02-12
Successor
Paul Wierbicki
Filed
February 18, 2025, 6:59 PM ET
On February 12, 2025, Jeryl (Jeri) Hilleman resigned from the board of directors (the “Board”) of Cutera, Inc. (the “Company”), effective immediately.
On February 13, 2025, Tracy A. Embree, a member of the Board of Directors (the “Board”) of Louisiana-Pacific Corporation (the “Company”), notified the Company of her decision not to stand for re-election to the Board at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”).
On February 14, 2025, James J. Ritchie informed Kinsale Capital Group, Inc. (the “Company”) that he will not stand for re-election to the Company’s Board of Directors (the “Board”) when his current term expires at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
On February 12, 2025, Audrey Robertson, a member of the Board of Directors (the “Board”) of Liberty Energy Inc., provided notice of her intention to resign from the Board, effective upon and subject to ratification and confirmation by the United States Senate as the incoming Assistant Secretary of Energy, Efficiency and Renewables, in the Department of Energy of the United States.
Departed
Howard A. Levine
Senior Executive Vice-President and Chief Consumer Banking Officer
Howard A. Levine, Senior Executive Vice-President and Chief Consumer Banking Officer, agreed that Mr. Levine will step down from his positions with the Company and the Bank effective February 14, 2025
Departed
Kimberly Hammer
Senior Vice President, Chief Accounting Officer
Sunnova Energy International Inc.
Effective
2025-05-31
Filed
February 18, 2025, 6:59 PM ET
On February 14, 2025, Sunnova Energy International Inc. (the “Company”) and Ms. Kimberly Hammer, Senior Vice President, Chief Accounting Officer, confirmed the terms of Ms. Hammer’s separation of employment
Rosa Sugrañes, age 67, informed FHN that she will retire from the Board effective when directors are elected at the 2025 annual meeting of shareholders.
Steven M. Walker, the Chief Accounting Officer (principal accounting officer) and Assistant Treasurer of HEICO Corporation (“HEICO” or the "Company"), provided the Company notice of his retirement on February 10, 2025.
On February 13, 2025, Dr. Asha Collins resigned from the Board of Directors (the “Board”) of IDEXX Laboratories, Inc. (the “Company”), effective immediately.
Departed
Flavia B. Landsberg
Executive Vice President and Chief Financial Officer
On February 12, 2025, Flavia B. Landsberg, Executive Vice President and Chief Financial Officer of Pyxus International, Inc. (the "Company"), resigned from her positions with the Company effective February 28, 2025 to accept employment with another company.
On February 10, 2025, Andrew J. Paul notified Corsair Gaming, Inc. (the “Company”) of his retirement from his position as Chief Executive Officer and from the board of directors of the Company (the “Board”), effective July 1, 2025.
On February 14, 2025, Ronald Hunt, Chairman and director of the Company, notified the Company of his resignation as Chairman and director of the Company, effective immediately.
On February 12, 2025, the Board of Directors (the “Board”) of Entero Therapeutics, Inc. (the “Company”) terminated James Sapirstein as Chief Executive Officer of the Company, without cause, effective immediately.
On February 13, 2025, Susan E. Skerritt, a member of the Board of Directors (the “Board”) of Community Financial System, Inc. (the “Company”) notified the Company that she will not stand for re-election at the Company’s 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”) and will retire from the Board, effective immediately following the 2025 Annual Meeting.
As previously reported, Richard Roomberg resigned as Chief Financial Officer of TechPrecision Corporation (the “ Company ”), effective on February 14, 2025
Departed
Tim Haley
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Amy Guggenheim Shenkan
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Jason Pressman
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Tien Tzuo
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Omar Abbosh
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Sarah Bond
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Ken Goldman
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
John D. Harkey Jr.
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Joe Osnoss
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
Departed
Laura Clayton McDonnell
Director
ZUORA INC
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
In connection with the Merger, at the Effective Time, each of the directors of the Company (Tien Tzuo, Jason Pressman, Omar Abbosh, Sarah Bond, Laura Clayton McDonnell, Ken Goldman, Amy Guggenheim Shenkan, Tim Haley, John D. Harkey Jr. and Joe Osnoss) resigned as directors of the Company.
On February 11, 2025, Kathy Vrabeck, Chief Operating Officer of The Beachbody Company, Inc. (the “Company”), notified the Company that she will retire from the Company, effective as of April 1, 2025.
Departed
John Sperzel
President and Chief Executive Officer
T2 Biosystems, Inc.
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
John Sperzel, President and Chief Executive Officer, John Sprague, Chief Financial Officer, and Michael Gibbs, Senior Vice President and General Counsel, were terminated without cause from their respective positions, effective immediately.
Departed
Michael Gibbs
Senior Vice President and General Counsel
T2 Biosystems, Inc.
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
John Sperzel, President and Chief Executive Officer, John Sprague, Chief Financial Officer, and Michael Gibbs, Senior Vice President and General Counsel, were terminated without cause from their respective positions, effective immediately.
Departed
John Sprague
Chief Financial Officer
T2 Biosystems, Inc.
Effective
2025-02-14
Filed
February 14, 2025, 6:59 PM ET
John Sperzel, President and Chief Executive Officer, John Sprague, Chief Financial Officer, and Michael Gibbs, Senior Vice President and General Counsel, were terminated without cause from their respective positions, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.